Search
for
Sort by
Research 511–540 of 1000+
- Preferential Recognition of Hydroxyl Radical-Modified Superoxide Dismutase by Circulating Autoantibodies in Patients with Alopecia Areata
- Vitiligo: an evidence-based update. Report of the 13th Evidence Based Update Meeting, 23 May 2013, Loughborough, U.K.
- Birth, life, and death of the MAGE3 hypothesis of alopecia areata pathobiology
- Thyroid peroxidase antibodies in patients with telogen effluvium
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Telogen Effluvium after Anesthesia and Surgery
- Intralesional betamethasone as a therapeutic option for alopecia areata
- Pediatric Systemic Lupus Erythematosus
- Breast Implant-Associated Immunological Disorders
- Mesococktails and mesoproducts in aesthetic dermatology
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Audiological abnormalities in patients with alopecia areata
- Eyelash alopecia areata: case series and literature review
- Innate immunity and the regulation and mobilization of keratinocyte stem cells: are the old players playing a new game?
- Linear immunoglobulin A/immunoglobulin G bullous dermatosis associated with Vogt-Koyanagi-Harada disease
- Break Dancing: A New Risk Factor for Scarring Hair Loss
- A case of patchy alopecia areata sparing lesional greying hairs
- Australian resources for ethical participatory processes in public health research
- Alopecia Areata: A Review of the Genetic Variants and Immunodeficiency Disorders Associated with Alopecia Areata
- Distinct use of super-enhancer elements controls cell type–specific CD25 transcription and function
- The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity
- Alopecia areata and subsequent Marie Antoinette syndrome following COVID-19 infection and vaccination: A case report
- Frontal fibrosing alopecia and genital Lichen sclerosus: Single‐center experience
- Laser therapy in superficial morphea lesions – indications, limitations and therapeutic alternatives
- Efficacy of the phosphodiesterase-4 inhibitor, apremilast, in a patient with severe alopecia areata
- Eavesdropping on the conversation between immune cells and the skin epithelium
- Non-motor Comorbidity of Myasthenia Gravis: Myasthenia Gravis as a Systemic Immunological Disorder Involving Non-motor Systems
- Dermatological aspects of the S2k guidelines on Down syndrome in childhood and adolescence
- Acquired immunogenicity of DNA after modification with malondialdehyde in patients with alopecia areata
- Koebnerization secondary to microblading